Report : Europe Laboratory Information System (LIS) Market Forecast to 2028 – COVID-19 Impact and Regional Analysis – by Product (Standalone LIS and Integrated LIS), Delivery Mode (Cloud-Based Delivery Mode, Web-Based Delivery Mode, and On-Premises Delivery Mode), Component (Software and Services), and End User (Hospital Labs, Independent Labs, and Physician Office Labs)

At 10.0% CAGR, the Europe Laboratory Information System (LIS) market is speculated to be worth US$ 431.39 Million by 2028, says Business Market Insights

According to Business Market Insights’ research, the Europe laboratory information system (LIS) market was valued at US$ 244.03 million in 2022 and is expected to reach US$ 431.39 million by 2028, registering a CAGR of 10.0% from 2022 to 2028. Rising adoption of automation in laboratories and technological advancements in LIS are the critical factors attributed to the market expansion.    

Laboratory automation is emerging as an approach to minimize human involvement in laboratory processes. The automation of routine laboratory procedures with the help of dedicated workstations and system software helps to increase laboratory efficiency and enables researchers to concentrate on important tasks along with avoiding human errors. Laboratories are increasingly adopting laboratory information system (LIS) to maintain stringent regulatory compliance, uplift efficiency and productivity, and drive data security and integrity. According to a study published in the Journal of Lab Automation, the error incidences in fully automated, semi-automated, and manual operations are 1–5%, 1–10%, and 10–30%, respectively. The growing use of digital workstations, automated analyzers, and total laboratory automation (TLA) allows laboratory personnel to reassign activities and contribute a greater value to operations. Moreover, high volumes of data generated by laboratory systems is triggering the demand for effective data processing, analysis, and sharing methods, thereby highlighting the need of efficient and cost-effective solutions such as the LIS.

Laboratory management departments are facing many challenges with a rising population submitting larger number of samples to laboratories and a lack of personnel to process those samples. These challenges are compelling them to maintain their laboratory operations, as laboratories have to maintain control over the influx of samples as well as find the way to improve workflow to deliver patient results in a timely manner

Further, growing demand for data integration is another factor contributing to the laboratory information system (LIS) market growth. With pharmaceutical and biotechnological industries spending huge amounts on research and development activities, the scientific communities are generating huge volumes of data. The appropriate processing and interpretation of the collected data requires data integration solutions.

For instance, in 2000, Quest Diagnostics, a prominent independent testing laboratory, started providing their consumers with a direct access to test results through the website owned and managed by Caresoft Inc. It offers direct-to-consumer test result, thereby ensuring confidentiality and anonymity of patients. Manual processes and paper records may allow unauthorized access to data, which increases the chances of data manipulation, and hence, managing data integrity is a big challenge faced by laboratories dependent on manual operations. Increasing adoption of electronic health record (EHR) systems in outpatient clinics and hospitals, to mitigate the risks associated with manual operations, would fuel the demand for LIS. The systems also allow the use of laboratory data to offer safe and high-quality patient care. Thus, the growing focus on effective clinical workflow management, leading to the rise in automation if laboratory processes, is driving the laboratory information system (LIS) market growth.

On the contrary, limited expertise in healthcare IT domain hurdles the growth of Europe laboratory information system (LIS) market.

Based on product, the market is bifurcated into standalone LIS and integrated LIS. The standalone LIS segment held 67.2% market share in 2022, amassing US$ 164.01 million. It is projected to garner US$ 285.66 million by 2028 to expand at 9.7% CAGR during 2022–2028.

Based on delivery mode, the market is segmented into cloud-based delivery mode, web-based delivery mode, and on-premises delivery mode. The cloud-based delivery mode segment held 43.8% market share in 2022, amassing US$ 106.89 million. It is projected to garner US$ 198.18 million by 2028 to expand at 10.8% CAGR during 2022–2028.

Based on component, the market is segmented into software and services. The former held 84.0% market share in 2022, amassing US$ 204.94 million. It is projected to garner US$ 356.52 million by 2028 to expand at 9.7% CAGR during 2022–2028.  

By end user, the Europe laboratory information system (LIS) market is further segmented into hospital labs, independent labs, and physician office labs. With 54.2% share of the domain, the hospital labs segment dominated the market in 2022. It accrued US$ 132.39 million in 2022 and is estimated to generate US$ 231.16 million by 2028 to grow at a CAGR of 9.7% over the forecast period.

Based on country, the market is segmented into France, Germany, Italy, Spain, the UK, and the Rest of Europe. Our regional analysis states that Germany captured 27.3% market share in 2022. It was assessed at US$ 66.57 million in 2022 and is likely to hit US$ 120.14 million by 2028, exhibiting a CAGR of 10.3% during the forecast period.

Key players dominating the Europe laboratory information system (LIS) market are AAC Infotray AG; CompuGroup Medical; Illumina, Inc.; LabLynx, Inc.; LabVantage Solutions, Inc.; McKESSON CORPORATION; and Thermo Fisher Scientific Inc., among others.

  • In Nov 2021, Thermo Fisher Scientific announced the release of Thermo Scientific SampleManager LIS software version 21.0. New features in SampleManager LIS software version 21.0 include PostgreSQL database support, enhanced user interface for dynamic data approval, and statistical data analysis through integration with R Script with enhancements to the existing Electronic Lab Notebook, contract testing portal, and translation features. The release also delivers a significant product health update through the resolution of 190 SCR defects.
  • In July 2022, Whole Genome Bisulfite Sequencing (WGBS) is the gold standard for DNA methylation studies, providing base-level methylation quantification for all cytosines. Zymo-Seq WGBS Library Kit was used in this experiment, in combination with the Illumina DNA Prep library prep kit.

Contact Us
Contact Person: Sameer Joshi
Phone: +1- 646- 491- 9876
Email id:

Download Free PDF Brochure